Cas:52225-85-1 2-(3-Chloropropyl)pyridine manufacturer & supplier

Chemical Name:2-(3-Chloropropyl)pyridine

CAS.NO:52225-85-1

Synonyms:2-(3-Chloropropyl)pyridine

Molecular Formula:C₈H₁₀ClN

Molecular Weight:155.62500

HS Code:2933399090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:12.89000

Exact Mass:155.05000

LogP:2.25300

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-(3-Chloropropyl)pyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(3-Chloropropyl)pyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(3-Chloropropyl)pyridine Use and application,2-(3-Chloropropyl)pyridine technical grade,usp/ep/jp grade.

Related News: The entire set of results “strongly support” the Darzalex-Rd combo as a new standard of care for newly diagnosed, transplant-ineligible multiple myeloma patients, Thierry Facon, M.D., an investigator of the MAIA trial, said in a statement. 2-(3-Chloropropyl)pyridine manufacturer The entire set of results “strongly support” the Darzalex-Rd combo as a new standard of care for newly diagnosed, transplant-ineligible multiple myeloma patients, Thierry Facon, M.D., an investigator of the MAIA trial, said in a statement. 2-(3-Chloropropyl)pyridine supplier The firm announced its own acquisition of California-based chemical, manufacturing and control (CMC) advisor Chamow & Associates back in January to bolster Alira’s biologics manufacturing, quality assurance and regulatory compliance business. Further yet, 12 months ago, Alira picked up French consulting firm Care Factory for its data science experts and electronic health record database knowledge. 2-(3-Chloropropyl)pyridine vendor Like Altasciences, Alira has also placed an emphasis on the preclinical setting in recent months with its March hire of Nikole Siegmund as vice president of preclinical development. 2-(3-Chloropropyl)pyridine factory This decision has shaken the foundations of the scientific process and methods, said Dr. Jason Karlawish, co-director of the Penn Memory Center in Philadelphia. Karlawish ran one of the trial sites for the Biogen drug.